Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
-
Late annual account NBB
Fiscal year 2025 was filed 228 days after the legal deadline.
Financials
Financial year 2025
PENTA APOTHEEK from Kortrijk, company number BE0822715297, closed financial year 2025 with a result of € 19,009 after tax. For that financial year PENTA APOTHEEK recorded a gross margin of € 126,781 and equity of € -223,544. Compared with financial year 2024, the result moved from € 19,863 to € 19,009. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 15, 2026.
€ -223,544
▲ € 19,009 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 19,009
▼ 4% vs 2024
Profit after tax over the fiscal year.
€ 27,664
▼ 50% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -242,144.
People and assets in 2025
1.1
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 100,994
▲ 21% vs 2024
€ 91,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 331,729
▲ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 42,138
▲ 46% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 154,573 | € 64,149 | € 105,613 | € 126,781 | ▲ 20% |
| Profit after taxes | € 81,350 | € -36,789 | € 19,863 | € 19,009 | ▼ 4% |
| Equity | € -225,627 | € -262,416 | € -242,552 | € -223,544 | ▲ € 19,009 |
| Total debts | € 442,776 | € 550,252 | € 550,806 | € 583,692 | ▲ 6% |
| Cash | € 29,389 | € 45,632 | € 55,106 | € 27,664 | ▼ 50% |
| Retained profit | € -244,227 | € -281,016 | € -261,152 | € -242,144 | ▲ € 19,009 |
| Bank debt | € 38,734 | € 25,695 | € 12,406 | € 0 | ▼ 100% |
| Balance sheet total | € 217,149 | € 287,836 | € 308,254 | € 360,148 | ▲ 17% |
| Employees (FTE) | 1 | 1 | 1 | 1.1 | ▲ 0.1 |
Key figures of PENTA APOTHEEK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to PENTA APOTHEEK?
What happened at PENTA APOTHEEK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 19,009 (▼ 4% vs 2024). filed late Source: NBB ↗
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
In short
From € 81,350 profit in 2022 to € 19,009 profit in 2025.
Best year ever: 2022, with € 81,350 profit.
On average € 115,300 of value added per employee in 2025.
A new publication or filing at PENTA APOTHEEK? We notify you, reason included.
Follow PENTA APOTHEEKDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PENTA APOTHEEK are Filip Vansteelant and Jocelyne Leterme. The same people are also behind PHARMGETH. Jocelyne Leterme is also behind PHARMACIE CASTRIQUE.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Gullegemsesteenweg(Bis) 134
8501 Kortrijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0822.715.297
- VAT number
- BE 0822.715.297
- Registered office
- Gullegemsesteenweg(Bis) 134, 8501 Kortrijk
- Names & denominations
- PENTA APOTHEEK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 January 2010
- Peppol
- Active · Active since 19 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Vervaardiging van farmaceutische grondstoffen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels